e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
Antibiotic therapy for pneumonia and pleural infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Methicillin-susceptible Staphylococcus aureus in Community-Acquired Pneumonia: Risk Factors and Outcomes
C. Cilloniz Campos (Barcelona, Spain), C. Dominedò (Roma, Italy), A. Gabarrus (Barcelona, Spain), C. Garcia-Vidal (Barcelona, Spain), E. Moreno (Barcelona, Spain), C. Vargas (Barcelona, Spain), A. Torres (Barcelona, Spain)
Source:
Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Session:
Antibiotic therapy for pneumonia and pleural infections
Session type:
Oral Presentation
Number:
4671
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Cilloniz Campos (Barcelona, Spain), C. Dominedò (Roma, Italy), A. Gabarrus (Barcelona, Spain), C. Garcia-Vidal (Barcelona, Spain), E. Moreno (Barcelona, Spain), C. Vargas (Barcelona, Spain), A. Torres (Barcelona, Spain). Methicillin-susceptible Staphylococcus aureus in Community-Acquired Pneumonia: Risk Factors and Outcomes. 4671
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
LATE-BREAKING ABSTRACT: Molecular and Phenotypic Characters of Methicillin-resistant
Staphylococcus
aureus
Isolates from Patients with Empyema Thoracis in Central Taiwan
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Efficacy of Ceftolozane/Tazobactam in Comparison with Piperacillin/Tazobactam in Severe Pseudomonas aeruginosa Pneumonia Swine Model
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Streptococcus pneumoniae as a Cause of Community-Acquired Pneumonia in Portuguese Adults: A single-center retrospective study
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Inoculation Pneumonia Caused by Coagulase Negative Staphylococcus in Mice
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Pseudomonas, enterobacteriaceae ESBL positive and staphylococcus MRSA: When to suspect them in CAP?
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Risk factors for methicillin-resistant Staphylococcus aureus isolation from serially obtained sputum in patients hospitalized with pneumonia
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020
Emerging macrolide-resistant
mycoplasma pneumoniae
in Thailand
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Screening for methicilin-resistant staphylococcus aureus colonization: A pulmonology department experience
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Pseudomonas aeruginosa
pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Clinical impact of a prediction score for drug-resistance in community-onset pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Molecular mechanisms and virulence of colistin-resistant klebsiella pneumoniae
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009
Methicillin-resistant
staphylococcus aureus:
The most prevalent cause of ventilator associated pneumonia in Tehran hospitals
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant
staphylococcus aureus
(CA-MRSA)
Source: Eur Respir J 2007; 30: Suppl. 51, 407s
Year: 2007
Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009
Twenty-year Trend in Mortality among Hospitalized Patients with Pneumococcal Community-Acquired Pneumonia
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Community-associated methicillin-resistant
staphylococcus aureus
(CA-MRSA) as a cause of hospital-acquired pneumonia (HAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 410s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept